A Study of JNJ-75229414 for Metastatic Castration-resistant Prostate Cancer Participants

Clinical trial NCT05022849 · COMPLETED

Trial details

NCT number: NCT05022849
Sponsor: Janssen Research & Development, LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Prostatic Neoplasms

Start date: 2021-09-28
Primary completion: 2026-03-11
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.